trending Market Intelligence /marketintelligence/en/news-insights/trending/rR2wLrf8RhQNwrjT4LZ0pg2 content esgSubNav
In This List

Galena Biopharma, Cardinal Health settle product swap disputes

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Galena Biopharma, Cardinal Health settle product swap disputes

Galena Biopharma Inc. agreed to settle all of its outstanding disputes with Cardinal Health Inc. over a product swap agreement.

Under the deal, Galena Biopharma will pay $500,000 to Cardinal Health. In turn, Cardinal Health will destroy all of the Zuplenz product returned due to the product swap. The related product swap agreement was also terminated as of the settlement date.

The companies entered into the agreement Sept. 25.